1. Chikkamath SB, Katageri GM, Mallapur AA, Vernekar SS, Somannavar MS, Piaggio G, et al. Duration of third stage labour and postpartum blood loss: a secondary analysis of the WHO CHAMPION trial data. Reprod Health. 2021;18(1):1-7. [
DOI:10.1186/s12978-021-01284-8] [
PMID] [
PMCID]
2. Gallos ID, Papadopoulou A, Man R, Athanasopoulos N, Tobias A, Price MJ, et al. Uterotonic agents for preventing postpartum haemorrhage: a network meta‐analysis. Cochrane Database Syst Rev. 2018;4(4):CD011689. [
DOI:10.1002/14651858.CD011689.pub3] [
PMID]
3. Kandil M. The sky rocketing rate of cesarean section in Egypt. Glob Drugs Therap. 2018;3(4):1. [
DOI:10.15761/GDT.1000153]
4. Ngwenya S. Postpartum hemorrhage: incidence, risk factors, and outcomes in a low-resource setting. Int J Womens Health. 2016;8:647-50. [
DOI:10.2147/IJWH.S119232] [
PMID] [
PMCID]
5. Elbohoty AEH, Mohammed WE, Sweed M, Bahaa Eldin AM, Nabhan A, Abd-El-Maeboud KHI. Randomized controlled trial comparing carbetocin, misoprostol, and oxytocin for the prevention of postpartum hemorrhage following an elective cesarean delivery. Int J Gynaecol Obstet. 2016;134(3):324-8. [
DOI:10.1016/j.ijgo.2016.01.025] [
PMID]
6. Oladapo OT, Fawole B, Blum J, Abalos E. Advance misoprostol distribution for preventing and treating postpartum haemorrhage. Cochrane Database Syst Rev. 2012;6(2020):CD009336. [
DOI:10.1002/14651858.CD009336.pub3] [
PMCID]
7. Shakur H, Beaumont D, Pavord S, Gayet-Ageron A, Ker K, Mousa HA. Antifibrinolytic drugs for treating primary postpartum haemorrhage. Cochrane Database Syst Rev. 2018;2(2):Cd012964. [
DOI:10.1002/14651858.CD012964] [
PMID] [
PMCID]
8. Shady NW, Sallam HF, Elsayed AH, Abdelkader AM, Ali SS, Alanwar A, et al. The effect of prophylactic oral tranexamic acid plus buccal misoprostol on blood loss after vaginal delivery: a randomized controlled trial. J Matern Fetal Neonatal Med. 2019;32(11):1806-12. [
DOI:10.1080/14767058.2017.1418316] [
PMID]
9. Jagielska I, Kazdepka-Ziemińska A, Kaczorowska A, Madej A, Kolossa T, Grabiec M. Evaluation of carbetocin and oxytocin efficacy in prevention of postpartum hemorrhage in women after cesarean section. Ginekologia Polska. 2015;86(9):689-93. [
DOI:10.17772/gp/59023] [
PMID]
10. Doctorvaladan SV, Jelks AT, Hsieh EW, Thurer RL, Zakowski MI, Lagrew DC. Accuracy of blood loss measurement during cesarean delivery. Am J Perinatol Rep. 2017;7(02):e93-00. [
DOI:10.1055/s-0037-1601382] [
PMID] [
PMCID]
11. Lilley G, Burkett-st-Laurent D, Precious E, Bruynseels D, Kaye A, Sanders J, et al. Measurement of blood loss during postpartum haemorrhage. Int J Obstet Anesth. 2015;24(1):8-14. [
DOI:10.1016/j.ijoa.2014.07.009] [
PMID]
12. Mahinthan V, Nicklin A, Tanqueray T. P. 46 Carbetocin vs oxytocin in the prevention of postpartum haemorrhage in caesarean section: A retrospective analysis. Int J Obstet Anesth. 2021;46(1):103044. [
DOI:10.1016/j.ijoa.2021.103044]
13. Ugwu IA, Enabor OO, Adeyemi AB, Lawal OO, Oladokun A, Olayemi O. Sublingual misoprostol to decrease blood loss after caesarean delivery: A randomised controlled trial. J Obstet Gynaecol. 2014;34(5):407-11. [
DOI:10.3109/01443615.2014.899329] [
PMID]
14. Gupta P, Sunita J, Shekhar C. Misoprostol versus oxytocin in prevention of postpartum hemorrhage. J Androl Gynaecol. 2016;4(1):1-4. [
DOI:10.13188/2332-3442.1000027]
15. Adanikin AI, Orji E, Adanikin PO, Olaniyan O. Comparative Study of Rectal Misoprostol to Oxytocin Infusion in Preventing Postpartum Haemorrhage After Caesarean Section. J Obstet Gynaecol. 2013;8(2):34-7. [
DOI:10.3126/njog.v8i2.9767]
16. Dk U. Impact of Preoperative Rectal Misoprostol on Blood Loss during and after Elective Cesarean Delivery: A Randomized Controlled Trial. Nepal J Obstet Gynaecol. 2016;11(2):37-41. [
DOI:10.3126/njog.v11i2.17460]
17. Nayak L, Pradhan K, Mishra S. Role of 400 mcg intraoperative sublingual misoprostol for reduction of caesarean blood loss. J Evid Based Med Healthcare. 2017;4:573-7. [
DOI:10.18410/jebmh/2017/112]
18. Musa AO, Ijaiya MdA, Saidu R, Aboyeji AP, Jimoh AA, Adesina KT, et al. Double-blind randomized controlled trial comparing misoprostol and oxytocin for management of the third stage of labor in a Nigerian hospital. Int J Gynaecol Obstet. 2015;129(3):227-30. [
DOI:10.1016/j.ijgo.2015.01.008] [
PMID]
19. Patil NB, Patted SS. A randomised controlled trial of oral misoprostol vs injection methylergometrine for prevention of post partum hemorrhage. Int j Reprod Contracept Obstet Gynecol. 2013;2(3):296-304. [
DOI:10.5455/2320-1770.ijrcog20130908]
20. Rajaei M, Karimi S, Shahboodaghi Z, Mahboobi H, Khorgoei T, Rajaei F. Safety and Efficacy of Misoprostol versus Oxytocin for the Prevention of Postpartum Hemorrhage. J Pregnancy. 2014;2014:713879. [
DOI:10.1155/2014/713879] [
PMID] [
PMCID]
21. Abd El Aziz MA, Iraqi A, Abedi P, Jahanfar S. The effect of carbetocin compared to misoprostol in management of the third stage of labor and prevention of postpartum hemorrhage: a systematic review. Syst Rev. 2018;7:1-8. [
DOI:10.1186/s13643-018-0832-4] [
PMID] [
PMCID]
22. Hellgren M. Hemostasis during normal pregnancy and puerperium. Semin Thromb Hemost. 2003;29(2):125-30. [
DOI:10.1055/s-2003-38897] [
PMID]
23. Ducloy-Bouthors A, Broisin F, Keita H, Fontaine S, Depret S, Legoeff F, et al. Tranexamic acid reduces blood loss in postpartum haemorrhage. Crit Care. 2010;14(1):P370. [
DOI:10.1186/cc8602] [
PMCID]
24. Simonazzi G, Bisulli M, Saccone G, Moro E, Marshall A, Berghella V. Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials. Acta Obstet Gynecol Scand. 2016;95(1):28-37. [
DOI:10.1111/aogs.12798] [
PMID]
25. Shakur H, Roberts I, Fawole B, Chaudhri R, El-Sheikh M, Akintan A, et al. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet. 2017;389(10084):2105-16. [
DOI:10.1016/S0140-6736(17)30638-4] [
PMID]
26. Othman ER, Fayez MF, El Aal DEMA, El-Dine Mohamed HS, Abbas AM, Ali MK. Sublingual misoprostol versus intravenous oxytocin in reducing bleeding during and after cesarean delivery: A randomized clinical trial. Taiwan J Obstet Gynecol. 2016;55(6):791-5. [
DOI:10.1016/j.tjog.2016.02.019] [
PMID]
27. Li B, Miners A, Shakur H, Roberts I. Tranexamic acid for treatment of women with post-partum haemorrhage in Nigeria and Pakistan: a cost-effectiveness analysis of data from the WOMAN trial. Lancet Glob Health. 2018;6(2):e222-e8. [
DOI:10.1016/S2214-109X(17)30467-9] [
PMID]
28. Cordovani D, Balki M, Farine D, Seaward G, Carvalho JC. Carbetocin at elective Cesarean delivery: a randomized controlled trial to determine the effective dose. Can J Anaesth. 2012;59(8):751-7. [
DOI:10.1007/s12630-012-9728-2] [
PMID]
29. Ali AE-NAE -G, Nasr A, Ahmed H, et al. Carbetocin versus Oxytocin and Misoprostol in prevention of atonic post-partum hemorrhage in high risk patients planed for cesarean delivery. Int J Reprod Contracept Obstet Gynecol. 2017;7(1):10. [
DOI:10.18203/2320-1770.ijrcog20175824]
30. Elgafor el Sharkwy IA. Carbetocin versus sublingual misoprostol plus oxytocin infusion for prevention of postpartum hemorrhage at cesarean section in patients with risk factors: a randomized, open trail study. Arch Gynecol Obstet. 2013;288(6):1231-6. [
DOI:10.1007/s00404-013-2896-7] [
PMID]
32. Saoud F, Stone A, Nutter A, Hankins GD, Saade GR, Saad AF. Validation of a new method to assess estimated blood loss in the obstetric population undergoing cesarean delivery. Am J Obstet Gynecol. 2019;221(3):267.e1-.e6. [
DOI:10.1016/j.ajog.2019.06.022] [
PMID]